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Assessment of renal resistance index after captopril test by Doppler in
essential and renovascular hypertension. Ultrasonic duplex scanning has
been validated as a noninvasive method to evaluate the kidney arteries and
hemodynamic characteristics of renal blood flow in patients with renal
artery stenosis. The purpose of our study was to assess the changes in renal
vascular impedance in 22 patients with renovascular hypertension, as
compared with 45 essential hypertensives and 15 norniotensives, by using
the Doppler parameter resistance index (RI) before and after a captopril
oral test. After the captopril test the RI decreased significantly in the
stenotic artery (P < 0.05). Univariate analysis showed that PRA values
after captopril correlated inversely with the changes of RI only in the
stenotic artery (P < 0.05). Thus, our findings suggest that the application
of the captopril test to renal echo-Doppler may represent a feasible,
noninvasive, and inexpensively useful tool in the screening studies aimed
at diagnosing renovascular hypertension.
Several tests are now used to screen for and diagnose renovas-
cular hypertension, such as renal arteriography, captopril en-
hanced renal scintigraphy, digital subtraction angiography, ultra-
sonography and magnetic resonance imaging [1—4].
Ultrasonic duplex scanning is increasingly being used as a
reliable noninvasive technique for evaluating the kidney arteries
with some hemodynamic parameters such as the renal flow
velocity, pulsatility index and the resistance index in patients with
essential and renovascular hypertension [5—9].
In several pathological renal conditions, such as renovascular
hypertension, urinary tract obstruction, and renal transplant re-
jections, the renal Doppler found abnormally high resistance
indexes [10—12]. In fact, the ability of the resistance index (RI),
calculated by the means of a renal Doppler to detect changes in
the compliance of renal vessels, has already been shown in
previous studies [13, 14].
The purpose of the present study was to assess any specific
change in renal vascular impedance in patients with renovascular
hypertension compared with essential hypertensive and normo-
tensive subjects, by using the renal resistance index before and
following a captopril oral test.
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Methods
Patients and control subjects
The patients included in this study were selected from our
outpatient clinic of the Hypertension Unit at University of Turin.
From January 1990 to November 1994, we diagnosed 22 cases of
unilateral RAS by traditional diagnostic workup (positive capto-
pril test and abnormal captopril renal scintigraphy). The 22
angiographically-confirmed renovascular patients and 45 random-
ized essential hypertensive patients underwent a Doppler scan in
conjunction with captopril test. The diagnosis of renovascular
hypertension was unknown to the ultrasonographer performing
the Doppler study. Fifteen normal subjects were studied as
controls. All patients gave informed consent to participate to the
study.
The healthy control subjects were eight men and seven women
from 22 to 55 years of age (mean 40.1 18.6); their blood
pressure was within the normal range and they were receiving no
medication (for example, oral contraceptives). The 15 female and
30 male essential hypertensives, 23 to 60 years old, were classified
according to the 1993 Joint National Committee guidelines for
hypertension [15] as follows: stage 1 (mild, N = 15, mean 29.9
5.2 years), stage 2 (moderate; N = 15, mean 41.6 9.9 years), and
stage 3 (severe; N = 15, mean 48.6± 9.4 years). Classification was
based on the average of two or more blood pressure readings on
two or more occasions. Selection was based on blood pressure
levels that remained hypertensive or normotensive over a one-
year follow-up period. The 14 males and 8 females patients with
renovascular hypertension were between 20 to 74 years (mean
41.3 17.6 years). In all patients systolic, diastolic and mean
arterial pressure (MAP = 1/3 systolic BP +2/3 diastolic BP),
under baseline conditions and after oral captopril were calculated.
Clinical and biochemical assessment
Cardiac, renal, and hepatic diseases were excluded by clinical
examination which included a complete hematological status,
urine analysis and electrocardiogram. Patients received a stan-
dardized diet containing 150 mmol sodium a day and 70 mmol
potassium a day.
Secondary endocrine hypertension was excluded by a full
history and examination which included plasma renin activity,
plasma aldosterone and urinary catecholamines. In all hyperten-
sive patients plasma renin activity (PRA) and plasma aldosterone
were drawn at supine and upright positions. The PRA and plasma
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Table 1. Main clinical and biochemical parameters in studied
population
Hypertensiye patients
NormotensivesEssential Renovascular
Characteristics (N = 45) (N = 22) (N = 15)
Age years 40.1 9.9 41.3 17.6 40.1 18.6
Serum creatinine mg/di 0.8 0.1 1.1 0.4 0.6 0.2
MeanAPmmHg 116±14 121±4 0.5±5.2
Systolic AP mm Hg 150 13 162 14 125 2.4
Diastolic AP mm Hg 106 10 99 7 78 5.3
PRA I ngAl/mi/hr 1.3 1.5 1.9 1.3 —
PRA H ng Al/mi/hr 2.6 2.2 6.2 4.6 —
PRA III ngAi/mi/hr 2 1.2 10 5.7 —
Aldosterone Ipg/mi 141.6 121.3 220 76 —
Aldosterone II pg/mi 222.4 134.2 378 146 —
Abbreviations are: I, supine; II, upright; III, after captopril test (50 mg
orally); AP, arterial pressure; PRA, plasma renin activity. Data are mean
SD.
Table 2. Resistance index baseline, after captopril and RI of the right
and left renal artery in normal subjects and essential hypertensives
N RI
RI after
captopril RI
Normal controls 15
Right 57.4 4.9 58.9 4.5 2.1 2.2
Left 56.6 4.1 59.0 4.2 2.4 1.9
Essential hypertensives 45
Right 59.2 5.1 61.1 4.9 1.1 3.6
Left 60.5 4.7 60.3 4.6 0.4 4.6
Data are mean values st.
aldosterone were measured by radioimmunoassay (RIA; Renckt,
Sorin, Italy). Further, a captopril oral test was performed, and
patients meeting all three criteria for a positive test result as
described by Muller et al [161 were considered to have a positive
test.
Radiology and scintigraphy
Patients with a positive captopril test were investigated further
by captopril-enhanced renal scintigraphy. The patients meeting a
true-positive captopril test, abnormal scintigraphic data with
regard to split renal function and renogram upslope additionally
underwent selective renal arteriography.
Angiography was performed with a femoral artery approach
and standard Seldinger techniques. The criterion used to diagnose
renovascular hypertension by angiography was a demonstration of
stenosis of 50% or more. The arterial diameters were measured
with a hand-held ruler.
Invasive angiographic study was not performed in patients with
a completely negative captopril test.
Doppler scanning method
Doppler US examinations were performed by two of the
authors (M.F., E.P.) in a blinded fashion, without knowledge of
clinical, scintigraphic and angiographic details.
In controls and in all hypertensive patients the evaluation of
renal artery flow characteristics and of renal vascular resistance
was also performed using renal Doppler before and after the
captopril test. All ultrasound examinations were performed with a
real-time/color-coded duplex scanner (Acuson 128/XPS, Acuson
Table 3. Resistance index baseline of the stenotic artery and normal
artery in 22 renovascular hypertensive patients, after captopril and RI
RI
RI after
captopril RI
Nonstenotic artery hilum
interlobar
66.5 10.8
64.2 12.2
66.9 10
63.2 13
0 1.4
—0.6 1.1
Stenotic artery hilum
interlobar
65.3 11.6
65.1 11.5
57.1 ll.7'
57.4 142h
—8.2 3.6a
—8.1 33
Data are mean values SD.
a P < 0.05 vs. nonstenotic artery
hP < 0.05 vs. baseline RI
Corporation, Mountain View, CA, USA) with a sector probe
model S328. The device consisted of a real-time two-dimensional
900 sector image, a range-gated pulsed Doppler velocimeter, and
a multijet color-coded analysis of Doppler signal. The imaging
and Doppler systems were operated at 3.5 MHz. The range of
depth was from 0 to 8 cm minimum and 0 to 24 cm maximum. The
Doppler beam axis with sample volume, the real-time renal image
with color-coded blood flow, and pulsed Doppler velocitograms
were all displayed on one monitor screen. The width of the sample
volume was 6 mm. Any of the real-time signals could be electron-
ically calculated by internal software programs. All subjects were
studied after overnight fasting. All medication had been with-
drawn two weeks prior to the study.
Patients were asked to lie down for one hour before the
examination. The examinations before and after captopril were
performed on the same day. Blood flow velocity was determined
in the proximal and distal portions of renal artery and in at least
three interlobar branches. In both kidneys the resistance index
(RI) as expression of arterial impedance was assessed in the hilum
and in at least three interlobar arteries by means of Doppler
velocitograms under baseline conditions. The same procedure was
followed when patients were given 50 mg captopril orally one hour
prior to the examination. To avoid possible side effects, patients
were kept in a supine position and their blood pressures moni-
tored every 15 minutes until the study was over. The resistance
index (RI) was electronically determined in both main renal
arteries. Its value was calculated by mathematical software with
the use of following formula: (peak systolic frequency shift —
lowest diastolic frequency shift)/peak systolic frequency shift. We
considered iRI to be the difference of RI values before and after
the captopril test; the LMAP to be the difference of mean arterial
pressure values before and after captopril test; and PRA to be
the difference of PRA values before and after captopril test.
Statistical analysis
The statistical analysis was performed by SAS system. Specific-
ity and sensitivity of Doppler captopril test, as well as its repro-
ducibility in the same subject and its predictive value were
calculated.
The difference among groups was tested by ANOVA, with a
P < 0.05 considered statistically significant. The difference be-
tween data obtained before and after the captopril test was tested
by the Student's t-test for paired data. To assess the difference
between RI of normal artery and stenotic artery in the same
subject, the Student's t-test for paired data was used. Strength of
the linear relationship between two variables was evaluated by
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Table 4. Changes in blood pressure (mm Hg) during study course
Before captopril After captopril
SBP DBP MAP ZMAPSBP DBP MAP
Normals 130 8 77 7 95 5 121 8 73 5 90 6 —6 3
Essential H. 163 21 102 12 122 11 149 19 91 ioa 110 9 —11 9
Renovascular H. 162 14 99 7 122 4 141 iia 88 5 105 2 —12 7
Abbreviations are: SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; H, hypertensives. Values are expressed
as mean SD.
P < 0.05 vs before captopril
product-moment correlation (Pearson). Data were expressed as
mean SD.
Results
The main clinical and biochemical characteristics of the studied
population are summarized in Table 1. The normotensive and
essential hypertensive subjects were clinically screened to exclude
renovascular hypertension, as previously reported [17].
The data set generated for the 82 subjects was, therefore
composed of resistance index values obtained in 82 studies in 164
kidneys. There were no significant differences between the base-
line RI in the right and left renal arteries in all patients (Table 2).
Furthermore, no statistically significant difference was found
between baseline RI obtained from stenotic renal arteries in
renovascular patients and baseline RI of nonstenotic renal arter-
ies (Table 3).
In renovascular patients the mean variation of RI after the
captopril test (zRI) was positive in nonstenotic artery. This zRI
was significantly different when compared to that of the stenotic
artery (P < 0.05), where the variation was clearly negative (Table
3). In normotensive controls and in essential and renovascular
hypertensive patients, captopril administration induced a signifi-
cant decrease in blood pressure (all P < 0.05) without causing
symptomatic hypotension (Table 4).
The effects of varying threshold values of RI on the diagnostic
value of image-directed Doppler sonography after the captopril
test in RAS are summarized in Table 5. A cutoff RI of —5 seems
to be most suitable for the presence of hemodynamically-signifi-
cant unilateral RAS (Fig. 1).
The sensitivity and specificity of Doppler/captopril test in
detection of unilateral RAS were 93% and 91%, respectively.
The reproduciblity values of the Doppler/captopril test are
shown in Table 6.
No significant correlation was found between RI and the
zIMAP (r = 0.02, NS) in the groups of either normotensives,
essential hypertensive or renovascular hypertensive patients (non-
stenotic artery r =
—0.24, NS; stenotic artery r = 0.05, NS).
A significant inverse correlation was found between zRT of the
stenotic artery and the post-captopril variation of PRA (PRA;
r =
—0.62; P < 0.05). In contrast, there was no significant
correlation between i.'RI and PRA in nonstenotic artery (r =
—0.48; P = 0.26, NS) of renovascular patients.
The data of five patients with RAS who underwent angioplasty
or stenting are summarized in Table 7. There were no significant
differences in RI before and after the captopril test.
Discussion
The renal artery Doppler scan is highly effective in the evalua-
tion of blood flow characteristics and abnormalities in renovascu-
lar hypertension, providing a rational basis for the selection of
patients for arterial angiography [11, 18—20]. However, several
problems preclude a more general use of this procedure [14, 21,
22]. In fact, the results of selected studies have claimed to
visualize the renal artery in a variable percentage of patients
[23—25]. Further, ultrasound examination would probably fail to
detect the presence of an accessory renal artery or a branch
stenosis [26, 27]. Other studies have considered this technique
useful only when used in concert with other screening tests [1].
The purpose of the present study was to evaluate,by use of the
echo-Doppler technique, changes in resistance index as an expres-
sion of renal vascular impedance in patients with unilateral renal
artery stenosis under baseline conditions and following pharma-
cologic challenge with a converting enzyme inhibitor, such as
captopril. Our previous study ,howed that the values of resistance
index before and after angiotensin converting enzyme inhibition
in patients with essential hypertension, correlated with the degree
and the duration of hypertension [17]. These findings suggested
that at some point in the course of hypertension, the renal
vasculature became unresponsive to pharmacologic manipulation
because of a permanent intraparenchymal renal vascular injury,
perhaps associated with increased resistance to renal blood flow
[17, 28]. We therefore undertook the present study to evaluate the
responsiveness of the renal resistance index following pharmaco-
logic challenge with captopril in renovascular hypertensive pa-
tients. We found no significant differences of baseline RI between
nonstenotic and stenotic arteries. Following the captopril test the
RI, calculated by means of an echo-Doppler, decreased signifi-
cantly only in the stenotic artery. In contrast, no significant
variations were present in nonstenotic artery of the same patient.
The consistency of these results was then tested by univariate
analysis in an attempt to evaluate the influencing factors. We
found no significant correlations between the variations of RI and
the changes of blood pressure after captopril test.
In contrast, stimulated plasma renin values one hour after oral
captopril ingestion were inversely correlated with the changes of
RI in the stenotic artery. It is known that a kidney with renal
artery stenosis may exhibit impaired function during converting
enzyme inhibition [291. This phenomenon is thought to be due to
disruption of autoregulation of the glomerular filtration rate
which becomes dependent on angiotensin II under conditions of
low perfusion pressure; however, the overall renal function is
preserved by the contralateral kidney [30—33].
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tRI Sensitivity% Specificity%
Predic
Positive
%
tive value
Negative
%
Accuracy
%
—1 100 60 44 100 70
—3 93 85 65 97 87
—4 93 89 72 98 90
—5 93 91 76 98 92
—6 71 96 83 92 90
—7 57 95 80 88 87
—10 14 98 66 79 78
Similar changes of renal vascular function have been shown in
the two-kidney one-clip Goldblatt model of hypertension in the
rat, where the contralateral normal kidney showed a marked
increase in glomerular filtration rate [34, 35]. The same situation
can be found in patients with unilateral artery stenosis, where a
unilateral worsening in renal function induced by converting
enzyme inhibition can be identified by radioisotope renography
[33, 36—41]. Similarly, regarding captopril-enhanced renal scm-
tigraphy, to our knowledge there have been no previous studies on
the use of captopril to enhance the results of renal Doppler
scanning. We suggest that the application of the captopril test to
renal ultrasound studies could help evaluate the variations in the
renal arterial impedance, especially in the presence of renovascu-
lar disease. An asymmetric response of the resistance index
suggests the possibility of a unilateral functional renin-depen-
dency well demonstrated by the challenge of captopril. Several
studies provide evidence that in renovascular hypertension the
renin-angiotensin system is important in controlling glomerular
filtration rate at low renal perfusion pressure [42, 431. In fact, the
intact renin system is crucial to autoregulation of the glomerular
filtration rate, and the administration of an ACE inhibitor, such as
captopril, destroys the integrity of the system [34, 44]. Thus, the
reduction of intrarenal vasoconstrictor action of angiotensin II
following captopril administration, in a kidney with renal artery
stenosis, may lead to a reduction of renal vascular resistance that
results in characteristic features in the renal blood velocity
waveform. The pathogenesis of resistance index reduction during
ACE inhibition is not yet completely explained. However, our
findings do not support acute hypotension as a major contributing
factor, as there was no difference in the blood pressure fall in all
the groups of patients studied. The inverse correlation between
RI and LPRA in the stenotic artery would confirm the crucial
importance of the dependency on angiotensin II in a kidney with
renal artery stenosis [30—32].
In the present study we found baseline RI values similar to
those of Kliewer et al [14]. However, our data disagree with other
studies where significantly lower baseline RI were present only in
hemodynamically high-grade stenosis (> 70%) [45—47].
In conclusion, our study shows that the resistance index by
echo-Doppler following a captopril test has characteristic features
in patients with renovascular hypertension. Therefore, we suggest
that a captopril test in conjunction with a duplex scanning method
may represent a useful, noninvasive and easily accessible diagnos-
tic tool, since the examination can be performed as many times as
necessary to evaluate the presence of RAS and to follow up on the
results of angioplasty or stenting. In contrast, captopril scintigra-
phy, even if it is comparable for sensitivity and predictivity, is
more invasive, semiquantitative, expensive, ionizing, and it does
not provide complete information regarding the renal vascular
function in hypertensive patients. Finally, captopril-Doppler may
provide further useful pathophysiological information and could
represent a new procedure in the screening of renovascular
hypertension.
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Table 5. Effects of varying threshold values of iRI after captopril test
on diagnostic value of doppler sonography in RAS
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Fig. 1. Scatterplots of delta RI values, measured in renal interlobar arteries,
in essential hypertensives (N = 45) and renovascular patients (N = 22). The
cutoff value (—5) for RI is indicated by the horizontal bar.
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Table 6. Reproducibility of baseline and after captopril RI in
renovascular hypertensives (N = 6)
Standard Change Consistency Repeatability %
Normal artery
Baseline 64.3 7.9 —2.3 2.4 2.3 2.4 4.8 7.4
After captopril 64.5 7 0.3 0.8 0.6 0.6 1.6 2.4
Stenotic artery
Baseline 64.2 12.8 —1.6 1.7 1.9 1.3 3.4 5.2
After captopril 55.9 12.9 0.05 1.5 1.2 0.6 3 5.3
Value are means SD. Definitions are: Standard, average of first and
repeated measurement; Change, first measurement subtracted from re-
peated measurement; Consistency, difference between first and repeated
measurement with omission of the sign; Reproducibility, twice the stan-
dard deviation of the difference between paired measurement, keeping the
sign and assuming zero mean difference; Reproducibility coefficient,
percentage of the mean variation.
Table 7. Resistance index in renovascular patients after angioplasty
(N =5)
Post-captopril
Basal RI RI RI
Normal artery hilum 66.1 6.5 66 5.7 —0.1 1.6
interlobar 63.6 6.4 63.3 5.1 —0.3 1.4
Stenotic artery hilum 66.8 6.7 66 6.6 —1.2 3.3
(after angioplasty) interlobar 64.4 7.9 64.1 6.6 —0.3 1.4
Mean values SD. P NS
Reprint requests to Franco Veglio, M.D., Cattedra Medicina Interna,
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